UV GERMI: directors' dealings · France · AMF

About UV GERMI

UV GERMI is a French listed company on Euronext Growth Paris, identified by ISIN FR0011898584 and ticker ALUVI. Headquartered in Saint-Viance, in the Corrèze region of France, the company designs, manufactures and markets ultraviolet (UV)-based equipment used for the decontamination, disinfection and purification of water, air and surfaces. It employs around 50 people and is part of the French industrial initiative La French Fab. Founded in 2009 by André Bordas, UV GERMI was built around a specialized technological niche: using UV solutions to address environmental, health and industrial challenges. Its listing on Euronext Growth Paris in 2017 marked a key milestone, providing access to capital to support commercial expansion and innovation. Since then, the company has continued to strengthen its industrial footprint in France, maintaining design and production capabilities focused on proprietary UV systems assembled domestically. UV GERMI’s business model is centered on several product and service lines, including drinking water treatment, wastewater and process-water treatment, pool dechloramination, air treatment, and surface disinfection in sensitive environments. A notable feature of the company’s model is the recurring contribution from after-sales service and spare parts, which becomes more meaningful as the installed base grows. On the commercial side, UV GERMI serves local authorities, industrial clients and specialized customers, while also expanding internationally, with export sales increasingly concentrated outside Europe. The company holds a recognized position in the French UV water-treatment market, particularly in pool dechloramination, where it is described by industry ecosystem sources as a leading domestic reference. More than 3,000 public swimming pools have reportedly been equipped with its solutions, underscoring its strong presence in public infrastructure applications. Its value proposition is based on a non-chemical technology that supports safer operations, environmental performance and potentially lower operating costs compared with conventional methods. From a financial perspective, UV GERMI reported net revenue of €8.51 million in 2024, up 5.8%, with EBITDA margin reaching 12.2% and positive cash generation. In 2025, first-half revenue was more subdued, but management expects a rebound in the second half, supported by deferred orders and by the growing share of recurring service revenue. Overall, the company combines technological specialization, a meaningful installed base and gradual geographic diversification, which are important ingredients for medium-term growth.